These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19456251)

  • 21. The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma.
    Pakravan M; Beni AN; Ghahari E; Varshochian R; Yazdani S; Esfandiari H; Ahmadieh H
    Am J Ther; 2017; 24(6):e676-e680. PubMed ID: 26825486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular distribution studies of the topical carbonic anhydrase inhibitors L-643,799 and L-650,719 and related alkyl prodrugs.
    Grove J; Gautheron P; Plazonnet B; Sugrue MF
    J Ocul Pharmacol; 1988; 4(4):279-90. PubMed ID: 3246565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit.
    Chien DS; Sasaki H; Bundgaard H; Buur A; Lee VH
    Pharm Res; 1991 Jun; 8(6):728-33. PubMed ID: 2062802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
    Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
    J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iloprost, a stable prostacyclin analog, reduces intraocular pressure.
    Hoyng PF; de Jong N
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):470-6. PubMed ID: 2435669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ethacrynic acid on aqueous outflow dynamics in monkeys.
    Croft MA; Hubbard WC; Kaufman PL
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1167-75. PubMed ID: 8125728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.
    Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1006-16. PubMed ID: 24474276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of daily topical ethacrynic acid on aqueous humor dynamics in monkeys.
    Croft MA; Kaufman PL
    Curr Eye Res; 1995 Sep; 14(9):777-81. PubMed ID: 8529416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE; Perry CM
    Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4.
    Terao E; Nakakura S; Fujisawa Y; Fujio Y; Matsuya K; Kobayashi Y; Tabuchi H; Yoneda T; Fukushima A; Kiuchi Y
    Curr Eye Res; 2017 May; 42(5):738-742. PubMed ID: 27911106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the Antiglaucoma Agent JV-GL1 and Related Compounds in the Canine Eye.
    Woodward DF; Coleman RA; Woodrooffe AJ; Spada CS; Wang JW
    J Ocul Pharmacol Ther; 2020 Oct; 36(8):636-648. PubMed ID: 32640926
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF; Hubatsch DA; Amaris P
    BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between glaucoma eye drops and hyperemia.
    Yanagi M; Kiuchi Y; Yuasa Y; Yoneda T; Sumi T; Hoshikawa Y; Kobayashi M; Fukushima A
    Jpn J Ophthalmol; 2016 Mar; 60(2):72-7. PubMed ID: 26847553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.
    Salvá P; Costa J; Andreu D; Notivol R; Martínez M
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):203-8. PubMed ID: 10389123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
    Vooturi SK; Kadam RS; Kompella UB
    Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits.
    Pate DW; Järvinen K; Urtti A; Jarho P; Järvinen T
    Curr Eye Res; 1995 Sep; 14(9):791-7. PubMed ID: 8529418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Otrivine-antistin-pupil, corneal and conjunctival responses to topical administration.
    Trew DR; Wright LA; Smith SE
    Eye (Lond); 1989; 3 ( Pt 3)():294-7. PubMed ID: 2693136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications.
    Di Zazzo A; Roberti G; Mashaghi A; Abud TB; Pavese D; Bonini S
    J Ocul Pharmacol Ther; 2017 Nov; 33(9):670-677. PubMed ID: 29045169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension.
    Feldman RM
    J Ocul Pharmacol Ther; 2003 Feb; 19(1):23-35. PubMed ID: 12648301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.